including compounds and proteins, have been identified with anti-diabetic, anti-HIV, and 23
antitumor activities in both in vitro and in vivo investigations (for details see review (8)). 24
Special attention goes to its applications on tumor therapy. Early in 1983, Jilka and 25 colleagues found that an aqueous extract of BG fruits inhibited tumor formation in CBA/DI 26 tumor cells, P388 tumor cells, and L1210 tumor cells bearing CBA/H mice, which was 27 contributed partially by enhancement of immune functions (9) The unadsorbed fraction with hemagglutinating activity was loaded on a SP-Sepharose 23 column (buffer: 0.02 M NH 4 OAC). The unadsorbed fraction containing hemagglutinating 24 activity was applied to a Q-Sepharose column (buffer: 0.02 M NH 4 HCO 3 ). Bound proteins 25 were eluted sequentially with three concentrations of NaCl (0.2, 0.5, and 1M) in 0.02 M 26 NH 4 HCO 3 . The fraction eluted with 0.5 M NaCl was pooled, dialyzed, and loaded on a 27
Superdex 75 column. Pure MCL resided in the major peak. The purity of the acquired MCL fraction and its molecular weight (native conditions) 1 were investigated by 15% non-reducing SDS-PAGE (12, 13). N-terminal amino acid 2 sequence was analyzed using an HP 1000A Edman degradation unit and an HP 1000 3 HPLC system (Hewlett Packard) (14). Investigations of hemagglutinating activity, 4 ribosome inactivating activity, and sugar-specificity were performed using methods 5 previously described (13, 14) . Bioinformatic works, including sequence alignment (using 6 ClustalX 1.83, and boxShade server), construction of phylogenetic tree (using ClustalX 7
1.83 and TreeVier), and predictive 3-D structure (using the on line Phyre server) were 8 conducted as mentioned previously (8)
Cell Culture and cell viability assay 11
Human NPC cell lines CNE-1 (well-differentiated), and CNE-2 (poorly-differentiated) 12
were purchased from the Sun Yat-sen University of Medicinal Sciences, Guangzhou, CNE-2 cells were cultured in RPMI 1640 medium containing 10 % fetal bovine serum, 100 18 U/ml penicillin and 100 μg/ml streptomycin (Gibco). The NP 69 cells were cultured in 19 keratinocyte-SFM medium (Gibco) plus supplements for keratinocyte-SFM (Gibco) (14) . 20
All cell lines were maintained at 37 °C in a humidified incubator under an atmosphere of 21 95% air and 5% CO 2 . Logarithmically growing cells were incubated with increasing 22 concentrations (0~60 μM) of MCL for 24 to 48 h, and cell viability was determined by 3-(4, 23 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazo-lium bromide (MTT) assay (14) and by 24 counting the number of viable cells on the basis of trypan blue exclusion, respectively. 25
26

Assessment of apoptosis, chromatin condensation, and DNA fragmentation 27
Effects of MCL on apoptosis of tumor cell were examined with a FACSort flow cytometer 28 (Becton Dickinson, Cowley, UK) using annexin-V-FITC/ propidum iodide (PI) (BD 29
Phamingen, CA, USA) double staining as previously described (15 observations of apoptotic bodies and chromatin condensation were made with Hoechst 1 33342 staining (1 µM), and visualized under ultraviolet illumination with a NIKON TE2000 2 microscope (Nikon, Japan) (15) . Moreover, apoptotic bodies were counted in 3 different 3 fields of microscopic observation. One hundred cells were examined in one field. In 4 addition, DNA fragmentation was determined with TUNEL staining (green fluorescence), 5 using an In Situ Cell Death Detection Kit (Roche, Indianapolis, IN). Briefly, tumor cells 6
were treated with MCL (7.5 μM) for 24 h, followed by TUNEL staining according to the 7 manufacturer's instructions, and monitored by flow cytometry. 8 9
Assays of cell-cycle analysis and mitochondrial depolarization 10
The cell-cycle distribution of cells after MCL treatment (0~15 µM, 24 h) was studied by 11 using flow cytometry with PI staining (20 μg/ml PI in PBS, containing 1% Triton X-100 and 12 10 μg/ml RNase A) (16). On the other hand, measurement of changes of mitochondrial 13 transmembrane potential (ΔΨm) was made using the same procedure, but with JC-1 14 staining at a concentration of 2.5 µg/ml (15) . The mechanism is that JC-1 exists in 15 
Western blot analysis 21
Effects of MCL treatment on (a) the expression and phosphorylation of 22 mitogen-activated protein kinases (MAPKs), (b) the activation of apoptotic cascades, and 23 (c) the expression of Bcl-2 family proteins were determined by Western blot (18). Briefly, 24 cellular lysates were heated at 99 °C for 10 min in 6 x SDS loading buffer, followed by 25 SDS-PAGE. The proteins were transferred to a PVDF membrane, which was then 26 incubated with a primary antibody in 5% milk, followed by incubation with a horse radish 27 peroxidase (HRP)-conjugated anti-mouse or anti-rabbit secondary antibody and 28 visualized using the ECL detection system (Amersham Life Science, Piscataway, NJ). and 100 μM L-NAME (a NO synthase inhibitor), and (c) coincubated with 3.75 μM MCL 3 and 10 μM SB-203580 (a p38 MAPK inhibitor), respectively, for 24 h. L-NAME or 4 SB-203580 was added 1 h prior to MCL. Second, the generation of nitrite and nitrate, as 5 the surrogate markers for NO, in the cell culture supernatant was determined by using 6 Griess reagent as previously described (14, 15). 7 8
Animal studies 9
The in vivo antitumor activity of MCL was studied in athymic nude (nu/nu) mice following 10 the procedure reported elsewhere with modifications (7, 16 ). First, a total of 1 x 10 7 CNE-2 11 cells were trypsinized, washed with 1 x phosphate buffered saline (PBS), and injected 12 subcutaneously into the right flank of each mouse. Mice were checked each day for 13 xenograft/tumor development. Once the tumors were palpable, mice were randomly 14 (19) . 20
21
TUNEL staining assay 22
On day 16, all (remaining) mice were sacrificed, and sections of tumor tissue in both 23 groups were prepared. As mentioned above, TUNEL assay was carried out using an In 24
Situ Cell Death Detection Kit (Roche, Indianapolis, IN) as per manufacturer's instructions. 25
The cells were visualized under a light microscope, and the percentage of apoptotic cells 26 under 5 high-power fields (20 x) was calculated (7, 19) . 27
28
Statistical analysis 29
Results of all in vitro studies were collected from three independent experiments 30 Cancer Research. 
Results
5
A new effective method established for the isolation of MCL 6
The common way for the purification of MCL is to make use of galactopyranosyl 7 columns (such as cross-linked arabinogalactan, and galactosyl Sepharose 4B columns) 8 based on its galactose-specific activity (12, 13, 20-22). As Supplementary Fig. 1 illustrates, 9
here a new method has been established for the purification of MCL. MCL was 10 unadsorbed on Blue and SP Sepharose columns, but adsorbed on a Q Sepharose column 11 which could subsequently be eluted with 0.5 M NaCl. The eluate was finally loaded on a 12
Superdex 75 column, and purified MCL was acquired in fraction Sup1. MCL appeared as 13 a single band with a molecular weight near 130 kDa in SDS-PAGE under non-reducing 14 conditions (without β-mercaptoethanol). These findings are commensurate with previous 15 reports (12, 13). About 24 mg homogeneous MCL were harvested from 250 g dried seeds. 16
Though the current method is not as simple as the commonly used one-step purification 17 procedure, it owns a specific advantage. This method can be applied to the simultaneous 18 Fig. 2B ). Among the 6 RIPs, ricin and CS-RIP (a type II 5 RIP from Camellia sinensis) exhibited a relatively close evolutionary relationship with MCL. 6
Currently, only preliminary X-ray studies of MCL have been reported (12), and there is a 7 lack of detailed NMR spectroscopic data. By using the on-line Phyre server (24), a 8 predictive 3-dimensional structure (ribbon diagram) of MCL was generated 9
( Supplementary Fig. 2C ). 10
11
MCL induces cytotoxicity in NPC cells in a time-and dose-dependent manner 12
To investigate the in vitro antitumor activity of MCL, CNE-1 and CNE-2 cells were 13 
MCL induces apoptosis and DNA-fragmentation in vitro 23
To unveil the possible mechanism involved in the cytotoxicity of MCL, the event of 24 apoptosis was evaluated in MCL-exposed CNE-1 and CNE-2 cells. In this study, annexin 25 V/PI staining was used to monitor early (annexin V positive) and late apoptosis/necrosis 26 (both dyes positive). Compared with control, the percentage of cells in early apoptosis 27 increased in a dose-dependent manner after MCL exposure (0~15 μM, 24 h). including chromatin condensation, DNA fragmentation, and the formation of apoptotic 1 bodies were detected (15) . As shown in Fig. 2B and Fig. 2C , both NPC tumor cells 2 displayed features consistent with apoptosis including condensation of nucleus (arrows) 3 and formation of apoptotic bodies (asterisks; and C) after exposure to MCL (7.5 μM, 24 h) 4 compared with control. Consistently, the number of TUNEL-positive cells significantly 5 increased from a value near baseline to almost 40% in both cell lines after exposure to 7.5 6 μM MCL (Fig. 2D) . 
potential depolarization 10
To further investigate the mechanism of MCL-mediated apoptosis, cell cycle arrest and 11 mitochondrial membrane depolarization were analyzed by flow cytometry. As Fig. 3A  12 shows, MCL treatment resulted in a highly significant increase in the G1 population in a 13 dose-dependent fashion (p < 0.05 in each case). Since cyclin D1 and phospho-Rb reflect 14 G1 cell cycle progression (25, 26), changes of their protein levels after MCL exposure 15 were investigated. As Fig. 3B and 3C indicate, treatment with MCL produced a 16 time-related decrease of the protein levels of both cyclin D1 and phospho-Rb. In view of 17 the high frequency that G1 cell cycle arrest takes place in a p53-, and/or p21-dependent 18 way (27), changes of protein levels of p53 and p21 were also investigated. Interestingly, 19
MCL caused a dose-(3.75 and 7.5 μM) and time-dependent (24, 36, and 48 h) inhibition 20 of protein expression of both p53 and p21 (data not shown). On the other hand, the 21 percentage of cells with depolarized mitochondria increased in accordance with elevated 22 MCL concentration (0~15 μM, 24 h) in both CNE-1 and CNE-2 cells (Fig. 3D) . the production of nitrite and nitrate, in both mouse peritoneal macrophages and the two 13 types of NPC cells (Fig. 4B) , whereas coadministration of 100 μM L-NAME, a NO 14 synthase inhibitor (32), attenuated MCL-induced NO production. At the same time, the 15 positive control, blue tiger king lectin, also induced NO production (15) . There was no 16 detectable lipopolysaccharide (an environmentally available NO-inducer (14)) 17 contamination in MCL (data not shown). Furthermore, the NO production and cytotoxicity 18 induced by MCL at 3.75 μM was partially blocked by cotreatment with the p38 MAPK 19 inhibitor, SB-203580, at a dose of 10 μM (Fig. 4C) . These results suggested that MCL 20 treatment activated the p38 cascade and increased the downstream production of NO, 21 resulting in cell toxicity. 22
23
MCL activates caspase-mediated apoptosis but has no effect on the expression of 24 classic Bcl-2 family proteins in NPC cells 25
Apoptosis is executed by a group of cysteine-dependent aspartate-specific proteases 26 termed caspases which comprise two distinct classes, the initiators (such as caspase 8, 27 caspase 9) and the effectors (including caspase 3 and others) (33). We further elucidated 28 the involvement of such caspases in MCL-induced cell death. As shown in Fig. 5A and Fig. 29 
dependent activation of the initiator caspases 8 and 9, and the executor caspase 3 in both 1 CNE-1 and CNE-2 cells. Accordingly, caspase activation leading to PARP cleavage was 2 observed. Since caspase-9 activation is initiated by cytochrome c in cytoplasm (34, 35), 3
we further confirmed that MCL enhanced cytochrome c translocation into the cytoplasm 4 and in turn activated caspase 9 (Fig. 5C) . Furthermore, the caspase inhibitor Z-VAD-FMK 5 (20 μM) decreased MCL-induced apoptosis in both NPC cells (Fig. 5D) . On the other hand, 6
in view of the reports that some Bcl-2 family proteins are involved in caspase-mediated 7 apoptosis and cell cycle arrest (27), the protein levels of some representative Bcl-2 family 8 members were investigated. Unexpectedly, MCL did not significantly affect the protein 9 expression of Bid, Bak, and Bcl-2 even at the dose of 7.5 μM (near IC 50 value) after 10 treatment for 48 h (data not shown). 11
12
MCL halts the growth of CNE-2 cell xenograft tumors 13
After demonstrating the antitumor potential of MCL in vitro, we went on to assess its 14 effect in nude mice. After subcutaneous inoculation of nude mice with CNE-2 cells for 4 15 days, the tumor xenograft was palpable and treatment was initiated. Two groups were 16 involved in the experiments, including the MCL group treated with 1mg MCL/kg body 17 weight for 12 consecutive days (i.p., 1.0 mg/kg/day), while the control group was treated 18 with PBS instead. As shown in Fig. 6A , MCL halted tumor growth on the 4 th day (day 8) of 19 administration. This effect was consistent, and on the 12 th day (day 16), nearly 45% 20 reduction of tumor volume was observed. On day 16, all mice were sacrificed and the 21 mean tumor weights of both groups were compared. As Fig. 6B shows, MCL significantly 22 decreased the mean tumor weight compared with control group. The dose of MCL used 23 did not exhibit detectable toxicity to nude mice. In order to correlate the in vivo antitumor 24 activity of MCL with its apoptosis-inducing activity, tumor sections of both groups were 25 stained with TUNEL to compare the numerical difference in apoptotic cells. As shown in 26 inhibitor Gö6976 (40), lapatinib (also named as Tykerb, GW572016; the first dual kinase 11 inhibitor of EGFR and HER-2) (41) , and ApoG2 (the synthesized oxidation product of 12 apogossypol from the cotton plant Gossypium) (7, 16) . 13
In this study, we investigated the in vitro and in vivo antitumor activity of MCL toward 14
NPC cells. We established a new and effective liquid chromatographic technique for 15
purifying MCL (Supplementary Fig. 1 ). MCL used in this study exhibits previously reported The cytotoxicity and anti-proliferative activity of MCL on NPC cells were higher than 24 those in the normal NP69 cells (Fig. 1) . This may be caused by the numerical difference of 25 molecules recognizable by MCL lectin chain on the surface of the cells, for some 26 investigations found that changes in cell surface sugars are associated with the 27 development of cancer (43) . Subsequent studies showed that induction of tumor cell 28 apoptosis is responsible for the MCL effect. MCL increased the proportion of apoptotic 29 cells, caused chromatin condensation and nuclear fragmentation (Fig. 2) unique morphological nuclear changes of apoptosis (44) . At the same time, G1 phase cell 1 cycle arrest and mitochondrial damage were detected. It seems that MCL-induced 2 mitochondrial damage appears to be the cause rather than the effect of MCL-induced cell 3 death since the phenomenon was detectable as early as 3 h after treatment (data not 4 shown). These results agree with the prevailing response of most cancer cells exposed to 5 chemotherapeutic components (7, 16, 39) . 6
We then tried to reveal the molecular basis involved in MCL-induced G1 cell cycle 7
arrest. MCL caused a G1 cell cycle arrest which was (partially) contributed by decreased 8 levels of cyclin D1 and phospho-Rb which are key members involved in cell proliferation and JNK has been reported to play a significant functional role in cell death induction (19) . 25
And curiously, ERK phosphorylation has been linked with both antitumor (29) and 26 protumor (49) activities. Our results show that MCL induced the phosphorylation of p38 27 MAPK in both NPC tumor cells, and also increased the activation of JNK from different 28 time points. It is important to note that MCL caused an increase of p-ERK in CNE-1 cells 29 as well as attenuated ERK phosphorylation in CNE-2 cells (Fig. 4) 
Pharmacologic interruption of p38 MAKP signaling, by the specific inhibitor SB-203580, 2 weakened MCL lethality and the down-stream NO production, indicating that this pathway 3 plays an important part in cell death induction. The NO inducing activity of MCL is of more 4 than trivial interest since unphysiologically high levels of extracellular NO can induce 5 apoptosis or necrosis (15) . Both type I and type II RIPs (30, 31), and lectins (14, 15) have 6 been demonstrated with NO-inducing activity in mouse macrophages and/or tumor cells, 7
and which chain(s) of MCL contributes to the production of NO awaits elucidation. 8
Apoptosis is executed by caspases and caspase-3 is a key protease associated with 9 DNA fragmentation and apoptosis (39). Two main pathways have been involved in 10 activation of caspase-3 including the caspase-8 regulated plasma membrane extrinsic 11 pathway and the caspase-9 regulated cell damage intrinsic pathway (39). We determined 12 that MCL exposure caused direct activation of both caspase-8 and caspase-9, followed by 13 activation of caspase-3 and cleavage of PARP (one of the early DNA damage responses) 14 (Fig. 5) . These results again corroborate our observation that MCL caused the production 15 of DNA fragmentation and apoptotic bodies (Fig. 2) . Moreover, ΔΨm collapse is a 16 conspicuous feature of apoptosis and always coincides with activation of Bcl-2 family 17 members, the release of cytochrome c into the cytoplasm, and caspase activation (50, 51). 18
As expected, MCL treatment in NPC cells caused ΔΨm collapse (Fig. 3D) , cytochrome c 19 translocation into the cytoplasm (Fig. 5C) , and the activation of caspase 9 (Fig. 5A) . In 20 light of mitochondrial damage is usually associated with the generation of reactive oxygen 21 species (ROS) which could contribute to cell death (52), the effects of MCL in the 22 expression levels of ROS and antioxidants (e.g., reduced glutathione) warrants further 23
studies. 24
Based on the knowledge that (a) MCL could induce the damage of mitochondria and 25 cell cycle transition, and the activation of caspase cascades, (b) Bcl-2 family proteins play 26 multiple regulatory functions in signal transduction involved in these activities (7, 27) , we 27 further investigated changes in protein levels of some Bcl-2 family members in Bim EL , Bmf, Mcl-1 S , PUMA, and NOXA) (27). Three representative members from each 2 subfamily were included in this study including Bcl-2, Bak, and Bid. Bcl2 phosphorylation 3 has been shown to inhibit cell cycle progression by delaying the G1/S transition (27, 53). 4
Furthermore, the proapoptotic proteins Bak and Bid can inhibit cell cycle progression, 5 inhibit cell survival, and increase apoptosis (7, 27, 39) . Strikingly, MCL had no significant 6 effects on the production of these proteins. Hu and coworkers (7) studied the apoptotic 7 activity of ApoG2 toward NPC cells (including CNE-1 and CNE-2) and observed that 8
ApoG2 totally blocked the functions of Bcl-2 family proteins without affecting their 9 expression levels. Whether the same phenomenon is true of MCL remains to be 10 We thank Dr. Heiko Jahn (University of Bielefeld, Germany) for his kind assistance with 6 statistical analysis of data. 
